Archive
Small caps dip but FTSE100 drops 1.78%; Gulfsands big gainer
Small caps really didn't move much on a day which saw explosive action from the ECB and some fiery responses in the global market.
Company
Sareum Holdings PLC
LON:SAR
Sareum Holdings (AIM:SAR) is a clinical-stage biotechnology company developing next generation kinase inhibitors for autoimmune disease and cancer. The Company is focused on developing next generation small molecules which modify the activity of the JAK kinase family and have best-in-class potential. Its lead candidate, SDC-1801, simultaneously inhibits TYK2 and JAK1. SDC-1801 is a potential treatment for a range of autoimmune diseases, including psoriasis, and has completed Phase 1 clinical development.
239 stories · page 12 of 12
Blue chips dip after Draghi decision but AIM stays steady
The FTSE AIM 100 Index rose 3.04 points to 3272 by mid-afternoon
Risers and fallers: 88 Energy PLC, PPHE Hotels PLC, Origo Partners PLC...
Main share price risers and fallers in London at 16.15pm
Sareum Holdings is making considerable progress
"We are swiftly moving towards our goal of becoming a clinical-stage development company," said CEO, Dr Tim Mitchell
Archive
Proactive news summary: Avation PLC, Premier Oil, OPG Power Ventures and Real Good Food.
A round-up of news from the Proactive Investors universe.
Sareum submits cancer trial application
The application means a £200,000 success milestone payment from Cancer Research Technology to Sareum.
Investments and investor services
Risers and fallers: Sunrise , Jubilee , Sareum and more
IInvestors continued to bask in the glow from Sunrise Resources
Sareum shares shoot up on clinical trial application news
Shares in drug discovery group Sareum Holdings (LON:SAR) shot up as it updated on the clinical trial process for its lead cancer candidate.
Investments and investor services
Proactive news highlights: Europa Oil & Gas, Range Resources, CloudTag, African Potash and more...
There were a lot of boardroom changes made today in the small cap space
Sareum Holdings optimistic about 2016
Drug discovery group Sareum Holdings (LON:SAR) says it's optimistic about next year with two planned in-human clinical trials for its lead cancer candidate expected to start in early 2016.
Investments and investor services
Risers & Fallers: African Potash, Sierra Rutile, Rightster, GRIT, InternetQ, Trinity Exploration
A mixed reaction to changes to the board compositions of some companies.
Risers & Fallers: Vipera, ARM, Premier African Minerals, Northacre, Kingfisher and Premier Oil
Below are the main news-driven share price movements at 4pm.
Investments and investor services
Risers & Fallers: Black Sea Property, Trap Oil, Best of the Best, Afren, Emerging Metals Minerals
Below are some of the main news-driven share price changes at 12.00pm.